Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling.

Cell Rep Med · 2025 · PMC12711661 · PMID 41172996

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Mesothelin (MSLN) is another potential target that showed a slight trend toward being upregulated in RMC tissues compared with the PanSolid cohort ( Figure 4 ) but was significantly lower than the levels found in mesothelioma samples ( Figure 5 H).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.